Advances in the Treatment of Asthma

There are more than 100,000 patients with severe persistent asthma in Texas alone. Treatment options are limited and patient quality of life is often compromised. This course will review current and brand new options for treatment.

\r\nTotal Viewing Time: 35 minutes - 1 video
\r\nInstruction Format: Slide and Presentation On Demand Webinar
\r\nCost: Complimentary
\r\nCredit: 0.5 AMA PRA Category 1 Credit™ (Internet Enduring Material)
', image: 'http://pulmonology.broadcastmed.com/images/orlCMECourse/imgTeaser/lungs41.jpg' }); return false;">Share
  • Comment
  • Captions
  • More Information
  • Dominic deKeratry, MD

    Dominic deKeratry, MD

    Dr. Dominic deKeratry was born in Tulsa, Oklahoma and raised on the East Coast as part of a U.S. Navy family before settling in Amarillo, TX. He attended undergraduate school at Texas A&M University (TAMU) in College Station and medical school at the University of Texas Medical Branch at Galveston. View full profile

    More Information

    What kind of information would you like to request?     More Information       Make a Referral

    Leave this field empty

    Sorry CME is not currently available for this activity.

    There are more than 100,000 patients with severe persistent asthma in Texas alone. Treatment options are limited and patient quality of life is often compromised. This course will review current and brand new options for treatment.

    Target Audience:

    All medical staff practitioners who provide care for patients who are experiencing asthma.

    Educational objectives:

    Upon completion of this activity, participants should be able to:

    • Review current and brand new options for asthma treatment 
    • Understand the current/historical asthma epidemiology in US/Texas 
    • Understand newest available non-pharmacologic treatment options for patients with severe asthma

    Disclosures:

    Policies and standards of the Texas Medical Association, the Accreditation Council for Continuing Medical Education, and the American Medical Association require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.

    The following speakers/ planners have no relevant financial relationship to disclose:

    • St. David’s CME Steering Committee- Planners
    • Jen Cabrera, CME Market Program Coordinator- Coordinator

    The following speaker/ planner have the following information to disclose about their financial relationship:

    Speaker: Dominic deKeratry, M.D.
    Commercial Interest: Boston Scientific
    Financial Relationship: Speaker’s Bureau

    Accreditation and Credit Designation Statement:

    The St. David's HealthCare is accredited by the Texas Medical Association to provide continuing medical education for physicians. The St. David's HealthCare designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    TEXAS MEDICAL ASSOCIATION LOGOThe St. David’s HealthCare has been surveyed by Texas Medical Association (TMA) and awarded Accreditation with Commendation for 6 years as a provider of continuing medical education (CME) for physicians. TMA accreditation seeks to assure both physicians and the public that CME activities sponsored provided by St. David’s HealthCare meet the high standards of the accreditation requirements and policies as adopted by TMA. TMA rigorously evaluates the overall CME programs of Texas organization according to national criteria adopted by the Accreditation Council for Continuing Medical Education (ACCME).

    Release Date: 02/12/2013 | Last Review Date: 10/06/2014 | Expires: 02/12/2016

    For questions on CME accredited courses, contact Celina Rollins, St. David’s HealthCare: Continuing Medical Education Market Program Coordinator at Celina.Rollins@stdavids.com

    Comments